Dr. Andrew Kruse's lab at Harvard Medical School focuses on understanding the molecular mechanisms behind bacterial cell wall synthesis. They study essential enzymes responsible for creating and maintaining the cell wall, which are potential targets for new antibiotics. By using advanced techniques in structural biology and single-molecule fluorescence, the lab aims to uncover how these enzymes are activated and regulated, paving the way for antibiotic development.

Dr. Jeff Kuret's lab at Ohio State University focuses on understanding tau aggregates, which play a crucial role in Alzheimer's disease and related conditions. The research explores how tau proteins misfold and form unique structures that contribute to neurodegeneration. By studying these aggregates, the lab aims to develop better diagnostic tools and therapies for tauopathies by clarifying the molecular mechanisms involved in tau aggregation and how they can be targeted by small molecules.

Dr. John Cooper's lab studies how proteins regulate the assembly of actin filaments, which are crucial for cell shape and movement. By investigating the allosteric regulation of the actin capping protein, the lab aims to understand how certain protein interactions affect cellular motility in health and disease. Their work combines biochemistry, molecular genetics, and advanced imaging techniques to explore the mechanisms driving cell migration and actin dynamics.

Professor Raymond Trievel's lab at the University of Michigan studies how the bacteria Legionella pneumophila causes Legionnaires Disease, a severe form of pneumonia. The lab focuses on understanding specific proteins called lysine methyltransferases that help the bacteria survive and multiply within host cells by modifying histones, proteins that control gene expression. By exploring these molecular mechanisms, the lab aims to discover new therapeutic strategies to combat this dangerous pathogen.

Tamara O'Connor's lab at Johns Hopkins University focuses on understanding how bacterial pathogens, specifically Legionella pneumophila, utilize host cell organelles called peroxisomes to thrive and evade the immune system. The research aims to uncover new strategies to develop antibiotics that can target these mechanisms to combat infections effectively. By investigating the role of peroxisomes in bacterial growth and survival within host cells, the lab hopes to identify new therapeutic opportunities for treating infections.

Dr. James V Degregori's research lab at the University of Colorado Denver focuses on how respiratory viral infections, such as influenza and SARS-CoV-2, affect dormant cancer cells in the lungs and lead to breast cancer metastasis. The lab investigates the connections between inflammation caused by these infections and the awakening of dormant cancer cells that can result in serious health complications. Their work aims to uncover mechanisms to prevent cancer recurrence and develop strategies for early detection and risk mitigation in cancer survivors.

Dr. Jonathan R. Lai's lab at Albert Einstein College of Medicine focuses on developing immunotherapies using human antibodies to combat alphavirus infections, such as Chikungunya and Mayaro viruses. The lab studies how these viruses cause diseases like arthritis and seeks to create effective antibody combinations to enhance protection against these viral infections. Their research could lead to new therapeutic options for patients suffering from alphavirus-related illnesses.

Dr. Stephan Lammel's lab at UC Berkeley explores how certain brain systems influence behaviors related to reward and feeding. Using advanced techniques like optogenetics and fiber photometry, they investigate dopamine neurons and their role in learning and motivation. The lab's research has potential implications for treating disorders such as addiction and obesity by understanding how neural circuits operate in different contexts.

Dr. Robert Landick's research lab at the University of Wisconsin-Madison focuses on understanding how transcription processes are regulated in bacteria. By studying the interactions between RNA polymerase and regulatory molecules, the team seeks to uncover mechanisms that control gene expression through pausing and termination of transcription. This work has implications for antibiotics development and understanding gene regulation in human health.

The Lau Lab at Boston University Medical Campus studies how transposable elements, which are pieces of DNA that can move around in the genome, affect aging and neurodegenerative diseases like Alzheimer's and Parkinson's. They focus on the natural RNA interference (RNAi) system that helps to silence these elements and maintain genomic stability, particularly when they're activated during aging. The lab conducts research using genetic and genomic techniques, particularly in the Drosophila model, to explore the mechanisms by which transposable element RNAs are regulated in humans and their potential impact on diseases.

Dr. Seok-Yong Lee's lab at Duke University focuses on understanding how our bodies perceive different types of sensory information, like temperature and pain, through specialized proteins called sensory receptors. The goal is to uncover the molecular mechanisms that allow these receptors to function and to explore how genetic mutations can lead to sensory disorders. By doing this, the lab aims to develop new, non-opioid drugs to effectively treat chronic pain and itching without the side effects associated with current pain medications.

Dr. Moshe Levi's lab at Georgetown University studies how certain lipids and hormone receptors affect kidney health, especially in conditions like diabetes and obesity. They explore how the composition of these lipids can influence inflammation and mitochondrial function, which are critical for kidney disease progression. The lab uses advanced techniques to understand the underlying mechanisms of age-related kidney disease and how caloric restriction might help mitigate its effects.

Dr. Sheng Li's lab at the University of Southern California focuses on exploring how changes in the epigenome influence cell behavior, differentiation, and disease. By using advanced computational tools and next-generation sequencing data, the lab aims to uncover how epigenetic modifications regulate gene expression across the entire mouse genome. The research combines biochemistry and computational biology to enhance our understanding of cellular plasticity and heterogeneity, with the goal of creating valuable resources for the scientific community.

Dr. Zhipeng Li's lab at the University of Florida focuses on understanding the role of the trace element selenium in cellular health. Their research investigates how selenium metabolism affects cell survival and how cells adapt to low selenium levels, which is essential for maintaining redox balance and preventing cell death. By developing a unique low-selenium cell system, the lab aims to uncover mechanisms related to selenium regulation and its implications for diseases related to selenium dysregulation.

Dr. Weikai Li's lab at Washington University is focused on understanding the vitamin K cycle, which is essential for blood clotting and maintaining healthy bones and blood vessels. Their research aims to uncover the structural and functional mechanisms behind the proteins involved in this cycle, particularly how they can be modulated to improve anticoagulation therapy and support cardiovascular health. This work has important implications for treating diseases related to blood coagulation and cardiovascular disorders.

Jun Liu's lab at Cornell University studies the bone morphogenetic protein (BMP) signaling pathway, which is crucial for proper development and function in organisms. Using the model organism C. elegans, the lab investigates how various proteins and genetic factors regulate BMP signaling and its implications for diseases such as cancer and cardiovascular conditions. Their research aims to uncover the mechanisms behind BMP regulation, which could lead to new therapeutic strategies for disorders related to faulty BMP signaling.

Dr. Christopher D. Green's research lab examines how sexual differences affect the development of liver cancer, specifically hepatocellular carcinoma (HCC). By using animal models that mimic human obesity-related liver disease, the lab explores the roles of specific enzymes, particularly sphingosine kinase 2, in these processes. The findings aim to improve understanding of liver cancer risk in men and women, potentially leading to personalized treatment options.

Dr. Timothy R. Zacharewski's lab focuses on understanding how environmental contaminants, especially a compound called TCDD, contribute to liver diseases like non-alcoholic fatty liver disease (NAFLD). The lab investigates how TCDD affects liver metabolism and causes liver damage, aiming to identify potential treatments, such as Vitamin B12 supplementation, to protect the liver from these damaging effects. This research is important because NAFLD is a growing health issue in the United States, and better understanding could lead to better treatments.

Dr. Stavros Lomvardas's lab at Columbia University focuses on understanding how olfactory receptors work at the molecular level and how they influence brain connections. The team conducts research on gene expression in sensory neurons and how these processes can lead to precise brain functions. Their work has important implications for treating neurodevelopmental disorders and understanding the basic biology of the sense of smell.

Dr. Steven L. McKnight's lab focuses on understanding how certain proteins, made up of a limited number of amino acids, play crucial roles in cellular functions. These proteins, known as low complexity domains, are often disordered and involved in various cellular processes, including the formation of RNA-rich structures in cells. The lab's research aims to uncover the mechanisms by which these proteins assemble and regulate cellular activities, with implications for understanding diseases like neurodegeneration.